glycyrrhizic acid has been researched along with hesperetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Chen, H; Lan, J; Song, K; Wu, X; Zhang, F | 1 |
1 review(s) available for glycyrrhizic acid and hesperetin
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
1 other study(ies) available for glycyrrhizic acid and hesperetin
| Article | Year |
|---|---|
Preparation and in vitro/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Cornea; Corneal Ulcer; Drug Carriers; Drug Delivery Systems; Eye Infections, Bacterial; Glycyrrhizic Acid; Hesperidin; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Ophthalmic Solutions; Particle Size; Pharmaceutical Preparations; Rabbits; Staphylococcal Infections; Surface Properties | 2021 |